{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:22:47Z","timestamp":1793924567246,"version":"4.8.0"},"reference-count":64,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2020-803"],"award-info":[{"award-number":["075-15-2020-803"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Biologically active compounds of natural or synthetic origin have a complex structure and generally contain various structural groups among which polycyclic cage amines are found. Hexaazaisowurtzitanes are representatives of these amines and studies on their biological activity began less than two decades ago, starting with research on the environmental impact of CL-20. This research helped to evaluate the risks of potential pollution in the habitat environments of living organisms and determine whether the chemical compounds in question could be utilized in pesticides, herbicides, fungicides, or medicinal drugs. The nomenclature of hexaazaisowurtzitane compounds has recently been expanded significantly, and some of them have demonstrated promise in the design of medicinal drugs. This paper review studies the pharmacological activity of the acyl derivatives of hexaazaisowurtzitane. Most of the compounds have been found to possess a high analgesic activity, providing a solution to the pressing issue of pain management in current pharmacology. Analgesic drugs currently used in the clinical practice do not meet all of the efficacy and safety requirements (gastro-, nephro-, hepato-, haematotoxicity, etc.). The material presented in the seven sections of this paper highlights information about hexaazaisowurtzitane derivatives. Furthermore, they have been observed to exhibit anti-inflammatory, anticonvulsant, antihypoxic, and antimetastatic activities, which render them highly promising for evaluation in various fields of medicinal practice.<\/jats:p>","DOI":"10.3390\/molecules28248084","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T11:26:52Z","timestamp":1702639612000},"page":"8084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biological Activity of Hexaazaisowurtzitane Derivatives"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5817","authenticated-orcid":false,"given":"Daria A.","family":"Kulagina","sequence":"first","affiliation":[{"name":"Laboratory for Medicinal Chemistry, Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), 659322 Biysk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Sysolyatin","sequence":"additional","affiliation":[{"name":"Laboratory for Medicinal Chemistry, Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), 659322 Biysk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana G.","family":"Krylova","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kiseleva","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana N.","family":"Povetyeva","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena P.","family":"Zueva","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria V.","family":"Eremina","sequence":"additional","affiliation":[{"name":"Laboratory for Medicinal Chemistry, Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), 659322 Biysk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Alekseeva","sequence":"additional","affiliation":[{"name":"Laboratory for Medicinal Chemistry, Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), 659322 Biysk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3292-8336","authenticated-orcid":false,"given":"Svetlana V.","family":"Strokova","sequence":"additional","affiliation":[{"name":"Laboratory for Medicinal Chemistry, Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), 659322 Biysk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai I.","family":"Suslov","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim V.","family":"Zhdanov","sequence":"additional","affiliation":[{"name":"Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIP&RM), Tomsk National Research Medical Center, Russian Academy of Sciences, 634028 Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/prep.19970220502","article-title":"CL-20 performance exceeds that of HMX and its sensitivity is moderate","volume":"22","author":"Simpson","year":"1997","journal-title":"Propellants Explos. Pyrotech."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10573-005-0014-2","article-title":"Hexanitrohexaazaisowurtzitane (CL-20) and CL-20-based formulations (Review)","volume":"41","author":"Nair","year":"2005","journal-title":"Combust. Explos. Shock Waves"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/prep.200900057","article-title":"Tetraacetyl-dibenzyl-hexaazaisowurtzitane nitrosation\u2014Studies on scale-up synthesis of HNIW","volume":"35","author":"Maksimowski","year":"2010","journal-title":"Propellants Explos. Pyrotech."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chroma.2003.08.060","article-title":"Physico-chemical measurements of CL-20 for environmental applications","volume":"1025","author":"Paquet","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2004.07.115","article-title":"Nitroreductase catalyzed biotransformation of CL-20","volume":"322","author":"Bhushan","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/AEM.70.7.4040-4047.2004","article-title":"Initial reaction(s) in biotransformation of CL-20 is catalyzed by salicylate 1-monooxygenase from Pseudomonas Sp. Strain ATCC 29352","volume":"70","author":"Bhushan","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_7","unstructured":"Haley, M.V., Anthony, J.S., Davis, E.A., Kurnas, C.W., Kuperman, R.G., and Checkai, R.T. (2023, September 30). Toxicity of the Cyclic Nitramine Energetic Material CL-20 to Aquatic Receptors, Available online: https:\/\/apps.dtic.mil\/sti\/citations\/ADA473749."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1897\/03-308","article-title":"Acute and chronic toxicity of the new explosive CL-20 to the earthworm (Eisenia andrei) exposed to amended natural soils","volume":"23","author":"Robidoux","year":"2004","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1897\/06-361R.1","article-title":"Comparative neurotoxicity of two energetic compounds, hexanitrohexaazaisowurtzitane and hexahydro-1,3,5-trinitro-1,3,5-triazine, in the earthworm Eisenia fetida","volume":"26","author":"Gong","year":"2007","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11356-009-0117-5","article-title":"Neurochemical and electrophysiological diagnosis of reversible neurotoxicity in earthworms exposed to sublethal concentrations of CL-20","volume":"17","author":"Gong","year":"2010","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/es203642e","article-title":"Gene expression analysis of CL-20-induced reversible neurotoxicity reveals GABAA receptors as potential targets in the earthworm Eisenia fetida","volume":"46","author":"Gong","year":"2012","journal-title":"Environ. Sci. Technol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.scitotenv.2007.10.001","article-title":"Uptake of Hexanitrohexaazaisowurtzitane (CL-20) by the earthworm Eisenia Fetida through dermal contact","volume":"390","author":"Gong","year":"2008","journal-title":"Sci. Total Environ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00244-004-0231-9","article-title":"Effects of dietary administration of CL-20 on Japanese Quail Coturnix Coturnix japonica","volume":"49","author":"Bardai","year":"2005","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1897\/06-068R.1","article-title":"In vitro degradation of hexanitrohexaazaisowurtzitane (CL-20) by cytosolic enzymes of Japanese Quail and the rabbit","volume":"25","author":"Bardai","year":"2006","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13568-020-01136-x","article-title":"Isolation and identification of a novel bacterium, Pseudomonas sp. ZyL-01, involved in the biodegradation of CL-20","volume":"10","author":"Liu","year":"2020","journal-title":"AMB Expr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxres\/tfad004","article-title":"Salidroside protect Chinese hamster V79 cells from genotoxicity and oxidative stress induced by CL-20","volume":"12","author":"Li","year":"2023","journal-title":"Toxicol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00253-005-1992-4","article-title":"Biotransformation of CL-20 by a dehydrogenase enzyme from Clostridium sp. EDB2","volume":"69","author":"Bhushan","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/ijerph6041371","article-title":"Biodegradation of the High Explosive Hexanitrohexaazaisowurtzitane (CL-20)","volume":"6","author":"Karakaya","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/jo00292a015","article-title":"Poliazapolycyclics by Condensation of Aldehides with Amines. 2. Formation of 2,4,6,8,10,12-Hexabenzil-2,4,6,8,10,12-hexaazatertacyclo[5.5.0.05.9.03,11]dodecanes from Glyoxal and Benzilamines","volume":"55","author":"Nielsen","year":"1990","journal-title":"J. Org. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/S0960-894X(03)00599-7","article-title":"Cage amines as the stopper inhibitors of cholinesterases","volume":"13","author":"Lin","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_21","first-page":"431","article-title":"Synthesis and biological activity of 2,4,6,8,10,12-hexaazatetracyclo[5.5.0.03,11.05,9]dodecane derivatives","volume":"18","author":"Tolstikova","year":"2010","journal-title":"Chem. Sustain. Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/cjoc.20000180518","article-title":"Oxidation of N-benzyl groups","volume":"18","author":"Qiu","year":"2000","journal-title":"Chin. J. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jhet.5570370640","article-title":"New Precursors for hexanitrohexaazaisowurtzitane (HNIW, CL-20)","volume":"37","author":"Chung","year":"2000","journal-title":"J. Heterocycl. Chem."},{"key":"ref_24","first-page":"89","article-title":"Acylation of 4,10-dibenzyl-2,6,8,12-tetraacetyl2,4,6,8,10,12-hexaazaisowurtzitane","volume":"4","author":"Kubasova","year":"2016","journal-title":"Polzunovsky Vestn."},{"key":"ref_25","unstructured":"Golding, P., Maccuish, A.J., and Bellamy, A.J. (2003). Protection of Amine and Hydroxyl Groups Using Fluoroacylation. (WO2004076384A2), Patent."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/prep.200700004","article-title":"The Use of trifluoroacetyl as an N- and O-protecting group during the synthesis of energetic compounds containing nitramine and\/or nitrate ester groups","volume":"32","author":"Bellamy","year":"2007","journal-title":"Propellants Explos. Pyrotech."},{"key":"ref_27","first-page":"104","article-title":"N-acylation of tetraacetylhexaazaisowurtzitane","volume":"38","author":"Wang","year":"2010","journal-title":"J. Henan Norm. Univ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1039\/c3nj00532a","article-title":"Formyl azido substituted nitro hexaazaisowurtzitane\u2014Synthesis, characterization and energetic properties","volume":"37","author":"Dong","year":"2013","journal-title":"New J. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mencom.2016.03.019","article-title":"Acylation of 2,6,8,12-tetraacetyl-2,4,6,8,10,12- hexaazatetracyclo[5.5.0.03,11.05,9]Dodecane","volume":"26","author":"Kulagina","year":"2016","journal-title":"Mendeleev Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","article-title":"Computational platform Way2Drug: From the prediction of biological activity to drug repurposing","volume":"66","author":"Druzhilovskiy","year":"2017","journal-title":"Russ. Chem. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/1062936X.2012.657238","article-title":"In silico fragment-based drug design using a PASS approach","volume":"23","author":"Filz","year":"2012","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/SPC.0000000000000425","article-title":"Issues in the future development of new analgesic drugs","volume":"13","author":"Dickenson","year":"2019","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/2772432816666210811145249","article-title":"Progress in Analgesic Development: How to Assess its Real Merits?","volume":"17","author":"Kissin","year":"2022","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"key":"ref_34","first-page":"313","article-title":"Diclofenac: Novit\u00e0 su tollerabilit\u00e0 ed azione antinfiammatoria spinale","volume":"105","author":"Sandri","year":"2014","journal-title":"Minerva Medica"},{"key":"ref_35","unstructured":"(2023, November 30). Available online: https:\/\/www.drugs.com\/diclofenac.html."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.12968\/jpar.2017.9.12.522","article-title":"A review of ketorolac as a prehospital analgesic","volume":"9","author":"Mallinson","year":"2017","journal-title":"J. Paramed. Pract."},{"key":"ref_37","unstructured":"(2023, November 30). Available online: https:\/\/www.medizzine.com\/en\/patients\/drugs\/K\/ketorolac.php#d."},{"key":"ref_38","unstructured":"(2023, November 30). Available online: https:\/\/www.drugs.com\/cdi\/tramadol-tablets.html."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1517\/14656566.6.12.2117","article-title":"Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety","volume":"6","author":"Gates","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_41","unstructured":"(2023, November 30). Available online: https:\/\/www.drugs.com\/cdi\/meloxicam-tablets.html."},{"key":"ref_42","unstructured":"Krylova, S.G., Amosova, E.N., Zueva, E.P., Razina, T.G., Rybalkina, O.Y., Lopatina, K.A., Sysolyatin, S.V., Kalashnikov, A.I., Malykhin, V.V., and Dygai, A.M. (2015). 4-(3,4-Dibromothiophenecarbonyl)-2,6,8,12-Tetraacetyl-2,4,6,8,10,12-Hexaazatetracyclo[5,5,0,3,11,5,9]dodecane as Analgesic Agent and Method for Production Thereof. (2565766C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2565766C1\/en?oq=RU2565766."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1021\/acsomega.1c01786","article-title":"Discovery of a novel non-narcotic analgesic derived from the CL-20 explosive: Synthesis, pharmacology, and target identification of Thiowurtzine, a potent inhibitor of the opioid receptors and the ion channels","volume":"6","author":"Aguero","year":"2021","journal-title":"ACS Omega"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10517-021-05085-8","article-title":"Pharmacokinetics of a new analgesic on the basis of hexaazaisowurtzitane derivative","volume":"170","author":"Bryushinina","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_45","unstructured":"Krylova, S.G., Amosova, E.N., Zueva, E.P., Razina, T.G., Rybalkina, O.Y., Lopatina, K.A., Sysolyatin, S.V., Kalashnikov, A.I., Malykhin, V.V., and Dygai, A.M. (2015). 4,10-Bis((\u00b1)-5-Benzoyl-2,3-Dihydro-1h-Pyrrolo[1,2-a]pirrol-1-Carbonyl)-2,6,8,12-Tetraacetyl-2,4,6,8,10,12-Hexaazatetracyclo[5,5,0,3,11,5,9]dodecane as an Analgesic and Method for Its Obtaining. (2558148C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2558148C1\/en?oq=RU2558148C1."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s11094-021-02332-0","article-title":"Synthesis and analgesic activity of 4,10-bis((\u00b1)-5-benzoyl-2,3-dihydro-1hpyrrolo[1,2-a]pyrrole-1-carbonyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazatetracyclo[5,5,3,11,5,9]dodecane","volume":"54","author":"Kulagina","year":"2021","journal-title":"Pharm. Chem. J."},{"key":"ref_47","unstructured":"Krylova, S.G., Povetyeva, E.N., Suslov, N.I., Zueva, E.P., Nesterova, Y.V., Afanasyeva, O.G., Kulpin, P.V., Amosova, E.N., Razina, T.G., and Rybalkina, O.Y. (2020). 4,10-Di(ethoxyacetyl)-2,6,8,12-Tetraacetyl-2,4,6,8,10,12-Hexaazatetracyclo[5,5,0,3,11,5,9] Dodecane as an Analgesic Agent and a Method for Production Thereof. (2736936C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2736936C1\/en?oq=RU2736936C1."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10517-023-05679-4","article-title":"Antinociceptive effect of Ethowurtzine, a new compound from the class of hexaazaizowurzitane","volume":"174","author":"Krylova","year":"2022","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_49","unstructured":"Krylova, S.G., Povetyeva, E.N., Suslov, N.I., Zueva, E.P., Nesterova, Y.V., and Zhdanov, V.V. (2022). 4-(3,4-Dibromothiophenylcarbonyl)-2,6,8,10,12-Pentaacetyl-2,4,6,8,10,12-Hexaazaisowurtzitane as an Analgesic Agent and Method for Its Preparation. (2769523C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2769523C1\/en?oq=RU2769523C1."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11094-023-02848-7","article-title":"Synthesis and biological activity of 4-(3,4-dibromothiophenecarbonyl)-2,6,8,10,12-pentaacetyl-2,4,6,8,10,12-hexaazaisowurtzitane: A new non-narcotic analgesic of the hexaazaisowurtzitane class","volume":"57","author":"Eremina","year":"2023","journal-title":"Pharm. Chem. J."},{"key":"ref_51","unstructured":"Krylova, S.G., Povetyeva, E.N., Suslov, N.I., Zueva, E.P., Amosova, E.N., Zhdanov, V.V., Baibakova, O.V., Eremina, V.V., Kulagina, D.A., and Sysolyatin, S.V. (2023). 4,10-Di(Ethoxyacetyl)-2,6,8,12-Tetraacetyl-2,4,6,8,10,12-Hexaazatetracyclo [5,5,0,03.11,05.9]dodecane as an Anti-Inflammatory Agent. (2798994C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2798994C1\/en?oq=RU2798994C1."},{"key":"ref_52","unstructured":"(2023, December 01). Available online: https:\/\/www.drugs.com\/monograph\/carbamazepine.html."},{"key":"ref_53","first-page":"CD007124","article-title":"Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy","volume":"12","author":"Powell","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_54","unstructured":"Krylova, S.G., Povetyeva, E.N., Sysolyatin, S.V., Suslov, N.I., Zueva, E.P., Nesterova, Y.V., Afanasyeva, O.G., Lopatina, K.A., Kulpin, P.V., and Zhdanov, V.V. (2019). 4-(3,4-Dibromothiophenecarbonyl)-2,6,8,12-Tetraacetyl-2,4,6,8,10,12-Hexaazatetracyclo[5,5,0,3,11,5,9]dodecane Used as an Anticonvulsant. (2684107C1), RU Patent, Available online: https:\/\/patents.google.com\/patent\/RU2684107C1\/en?oq=RU2684107C1."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1527-3458.2005.tb00268.x","article-title":"Piracetam: A review of pharmacological properties and clinical uses","volume":"11","author":"Winblad","year":"2005","journal-title":"CNS Drug Rev."},{"key":"ref_56","unstructured":"(2023, December 01). Available online: https:\/\/www.drugs.com\/uk\/nootropil-800mg-tablets-leaflet.html."},{"key":"ref_57","unstructured":"Kulagina, D.A. (2018). Development of Methods for Synthesis of Acyl Derivatives of Hexaazaisowurtzitane. [Ph.D. Thesis, Tomsk Polytechnic University]. (In Russian)."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Caraceni, A., and Shkodra, M. (2019). Cancer pain assessment and classification. Cancers, 11.","DOI":"10.3390\/cancers11040510"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpainsymman.2023.07.014","article-title":"The need of a comprehensive approach in a condition of poorly opioid-responsive cancer pain","volume":"66","author":"Mercadante","year":"2023","journal-title":"J. Pain Symptom Manag."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Glavas Tahtler, J., Djapic, D., Neferanovic, M., Miletic, J., Milosevic, M., Kralik, K., Neskovic, N., Tomas, I., Mesaric, D., and Marjanovic, K. (2023). Long-term outcomes of breast cancer patients receiving levobupivacaine wound infiltration or diclofenac for postoperative pain relief. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092183"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1007\/s00520-019-04830-0","article-title":"A clinical approach to the management of cancer-related pain in emergency situations","volume":"27","author":"Burnod","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: Golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_63","unstructured":"(2023, December 01). Available online: https:\/\/www.drugs.com\/international\/cyclophosphamide.html."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.21294\/1814-4861-2020-19-2-76-81","article-title":"A New analgesic agent based on hexaazaisowurzitan: Feasibility of using in managing patients with cancer","volume":"19","author":"Lopatina","year":"2020","journal-title":"Sib. J. Oncol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/8084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:38:48Z","timestamp":1760132328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/8084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":64,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["molecules28248084"],"URL":"https:\/\/doi.org\/10.3390\/molecules28248084","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}